BRPI0915271A2 - composição de organo-gel fosfolipídico estruturado termorreversível, uso da composição de organo-gel fosfolipídico estruturado termorreversível, processo para a obtenção de um produto cristalino líquido e método de carregar organo-gel fosfolipídico estruturado termorreversível - Google Patents

composição de organo-gel fosfolipídico estruturado termorreversível, uso da composição de organo-gel fosfolipídico estruturado termorreversível, processo para a obtenção de um produto cristalino líquido e método de carregar organo-gel fosfolipídico estruturado termorreversível

Info

Publication number
BRPI0915271A2
BRPI0915271A2 BRPI0915271A BRPI0915271A BRPI0915271A2 BR PI0915271 A2 BRPI0915271 A2 BR PI0915271A2 BR PI0915271 A BRPI0915271 A BR PI0915271A BR PI0915271 A BRPI0915271 A BR PI0915271A BR PI0915271 A2 BRPI0915271 A2 BR PI0915271A2
Authority
BR
Brazil
Prior art keywords
thermoreversible
structured phospholipid
organo gel
gel composition
organo
Prior art date
Application number
BRPI0915271A
Other languages
English (en)
Inventor
Bruce R Sebree
Shireen S Baseeth
Original Assignee
Archer Daniels Midland Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archer Daniels Midland Co filed Critical Archer Daniels Midland Co
Publication of BRPI0915271A2 publication Critical patent/BRPI0915271A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01—Other fatty acid esters, e.g. phosphatides
    • A23D7/011—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01—Other fatty acid esters, e.g. phosphatides
    • A23D7/013—Spread compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/106—Adducts, complexes, salts of phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • General Preparation And Processing Of Foods (AREA)
BRPI0915271A 2008-11-14 2009-11-13 composição de organo-gel fosfolipídico estruturado termorreversível, uso da composição de organo-gel fosfolipídico estruturado termorreversível, processo para a obtenção de um produto cristalino líquido e método de carregar organo-gel fosfolipídico estruturado termorreversível BRPI0915271A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11451008P 2008-11-14 2008-11-14
PCT/US2009/064407 WO2010057007A1 (en) 2008-11-14 2009-11-13 Organogel compositions and processes for producing

Publications (1)

Publication Number Publication Date
BRPI0915271A2 true BRPI0915271A2 (pt) 2016-06-14

Family

ID=42170362

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0915271A BRPI0915271A2 (pt) 2008-11-14 2009-11-13 composição de organo-gel fosfolipídico estruturado termorreversível, uso da composição de organo-gel fosfolipídico estruturado termorreversível, processo para a obtenção de um produto cristalino líquido e método de carregar organo-gel fosfolipídico estruturado termorreversível

Country Status (13)

Country Link
US (1) US20110250299A1 (pt)
EP (2) EP2711001A3 (pt)
JP (2) JP6073552B2 (pt)
KR (1) KR101685218B1 (pt)
CN (3) CN103349285A (pt)
AU (2) AU2009313928B2 (pt)
BR (1) BRPI0915271A2 (pt)
CA (1) CA2743675A1 (pt)
CO (1) CO6361902A2 (pt)
IL (1) IL212839A (pt)
MX (1) MX2011005076A (pt)
WO (1) WO2010057007A1 (pt)
ZA (1) ZA201104382B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX339957B (es) * 2010-05-14 2016-06-20 Archer Daniels Midland Co Composiciones alimenticias que comprenden organogeles.
WO2011156803A2 (en) * 2010-06-11 2011-12-15 Transdel Pharmaceuticals, Inc. Anti-cellulite composition and method of treating cellulite
US9132291B2 (en) 2010-10-05 2015-09-15 Dfb Technology, Ltd. Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa
AR086993A1 (es) 2011-06-20 2014-02-05 Gen Biscuit Masa de galletita
AU2013262833A1 (en) * 2012-05-16 2014-12-04 Archer Daniels Midland Company Emulsifier for solubilizing polar solvents in oils and polyols
JP6241852B2 (ja) * 2012-05-25 2017-12-06 学校法人日本大学 レシチンオルガノゲル形成剤
US8617317B1 (en) 2012-07-31 2013-12-31 Ecolab Usa Inc. All-purpose cleaners with natural, non-volatile solvent
JP2016510740A (ja) * 2013-03-05 2016-04-11 アーチャー−ダニエルズ−ミッドランド カンパニー イソヘキシドモノトリフレートおよびそれを合成するプロセス
US9987215B2 (en) * 2013-03-22 2018-06-05 Chemyunion Quimica Ltda. Structuring of cosmetic compostion using organogels
AU2014329412B2 (en) 2013-10-03 2020-02-27 Harrow Ip, Llc Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
CN103550138B (zh) * 2013-10-29 2015-11-25 中国药科大学 一种索拉非尼有机凝胶及其制备方法
CN104758971B (zh) * 2015-03-30 2017-08-25 南宁市化工研究设计院 一种纯天然的茉莉固体芳香剂的制备方法
KR101843423B1 (ko) * 2015-07-27 2018-05-14 씨제이제일제당(주) 유지의 항산화용 조성물, 이의 제조방법, 이를 함유하는 식용유 및 상기 식용유의 제조 방법
CN109772237B (zh) * 2019-01-24 2020-06-26 厦门大学 一种基于凝胶超高压液化包埋负载物的方法
WO2020243564A1 (en) * 2019-05-30 2020-12-03 Beckman Coulter, Inc. Methods and systems for immobilizing a biological specimen for microscopic imaging
CN118304253A (zh) * 2021-01-14 2024-07-09 南京清普生物科技有限公司 一种缓释制剂组合物
CN114191381B (zh) * 2021-11-29 2023-10-24 华南农业大学 一种温敏型模拟塑性脂肪、口腔质构及消化行为可控的双凝胶及其制备和应用
CN114601790A (zh) * 2022-04-07 2022-06-10 中国人民解放军空军军医大学 一种促进毛发生长的凝胶药物及其制备方法和应用
WO2023205649A1 (en) * 2022-04-18 2023-10-26 Massachusetts Institute Of Technology Crosslinked organogels for drug delivery

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241046A (en) * 1978-11-30 1980-12-23 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
DE3225705A1 (de) * 1982-07-09 1984-01-12 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zum ausbringen von pflanzenschutzmittelspritzbruehen durch verspruehen und verpackungseinheit fuer konzentrate
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
CA1263311A (en) * 1984-05-25 1989-11-28 George Wing-Yiu Tin Vesicle stabilization
JPS6229947A (ja) * 1985-07-31 1987-02-07 Ajinomoto Co Inc 難消化性多糖含有ゲルの製造法
JP2647082B2 (ja) * 1987-03-03 1997-08-27 旭電化工業株式会社 水中油型乳化用乳化組成物
KR900700079A (ko) * 1988-01-12 1990-08-11 후지하라 도미오 누출방지 리포좀 제제
DE4003783C2 (de) * 1990-02-08 1999-03-25 Nattermann A & Cie Phospholipidhaltiges Gel, Verfahren zu dessen Herstellung und Verwendung
JPH0539485A (ja) * 1991-08-02 1993-02-19 Kose Corp 液晶組成物及びこれを含有する化粧料
JPH0795931B2 (ja) * 1991-11-28 1995-10-18 キユーピー株式会社 容器入り水中油型乳化食品
FI100692B (fi) * 1994-05-24 1998-02-13 Leiras Oy Menetelmä farmaseuttisten koostumusten valmistamiseksi, jolloin koostu mukset pohjautuvat mikroemulsiogeeleihin sekä uusia mikroemulsioihin p ohjautuvia geelejä
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
JP3440388B2 (ja) * 1994-08-23 2003-08-25 旭電化工業株式会社 サラダ用酸性ペ−スト状水中油型乳化脂
US5639740A (en) * 1995-03-10 1997-06-17 Crandall; Wilson Trafton Topical moisturizing composition and method
US5945409A (en) * 1995-03-10 1999-08-31 Wilson T. Crandall Topical moisturizing composition and method
US6278004B1 (en) * 1996-11-06 2001-08-21 Aventis Pharma Deutschland Gmbh Stabilized phospholipidic composition
US5849315A (en) * 1997-05-08 1998-12-15 Isp Investments Inc. Emulsifier composition for skin care formulations
WO1998053800A1 (en) * 1997-05-29 1998-12-03 Applied Biotechnologies, Inc. Compositions and methods for preventing adhesion
JPH11240826A (ja) * 1997-12-26 1999-09-07 Kose Corp 化粧料
US7064114B2 (en) * 1999-03-19 2006-06-20 Parker Hughes Institute Gel-microemulsion formulations
US7033603B2 (en) * 1999-08-06 2006-04-25 Board Of Regents The University Of Texas Drug releasing biodegradable fiber for delivery of therapeutics
DE19940227A1 (de) * 1999-08-25 2001-03-08 Merckle Gmbh Phospholipidgel
US7419964B2 (en) * 1999-09-16 2008-09-02 Cytogenix, Inc. Treatment of HSV-related pathologies using ssDNA
CN1136841C (zh) * 2000-07-12 2004-02-04 曾群 组凝胶型脂质体及其组合物与应用
DE10036051A1 (de) * 2000-07-25 2002-02-07 Beiersdorf Ag Kosmetische oder dermatologische Formulierungen zur Pflege und Kühlung der Haut nach einem Sonnenbad
ITMI20010528A1 (it) * 2001-03-13 2002-09-13 Istituto Biochimico Pavese Pha Complessi di resveratrolo con fosfolipidi loro preparazione e composizioni farmaceutiche e cosmetiche
DE10213957A1 (de) * 2002-03-28 2003-10-09 Beiersdorf Ag Vernetzte kosmetische oder pharmazeutische phospholipidhaltige Gele und Emulsionen auf der Basis von ethylenoxidhaltigen oder propylenoxidhaltigen Emulgatoren
US20050095336A1 (en) * 2003-11-04 2005-05-05 Pete Maletto Low carbohydrate ice cream
BR0314065A (pt) * 2003-12-10 2005-07-19 Antonio Claudio Tedesco Emulsão gel/lìquida termo-reversìvel de agentes fotosensìveis e processo de esterilização da cárie, tratamento de periodontia e endodontìa ativadas por irradiação luminosa
US20050196434A1 (en) * 2004-03-04 2005-09-08 Brierre Barbara T. Pharmaceutical composition and method for the transdermal delivery of magnesium
KR20070057767A (ko) * 2004-06-15 2007-06-07 앤드류 셴 천 인지질 조성물 및 이의 제조 및 사용 방법
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
CN100341427C (zh) * 2005-03-16 2007-10-10 新疆生命红果蔬制品有限公司 乳化番茄红素及其制备方法
WO2007008557A1 (en) * 2005-07-07 2007-01-18 Caravan Ingredients Inc. Monoglyceride and emulsifier compositions and processes of producing the same
DE102005036497A1 (de) * 2005-07-28 2007-02-08 Coty Deutschland Gmbh Produkt der dekorativen Kosmetik mit hohem Wassergehalt
US9918934B2 (en) * 2006-12-12 2018-03-20 Edgar Joel Acosta-Zara Linker-based lecithin microemulsion delivery vehicles
CN101161084B (zh) * 2007-11-23 2010-12-15 华南理工大学 一种常温保存的植脂奶油的制备方法

Also Published As

Publication number Publication date
JP6073552B2 (ja) 2017-02-01
AU2009313928A1 (en) 2010-05-20
EP2711001A3 (en) 2014-07-02
KR20110083738A (ko) 2011-07-20
CN102264352A (zh) 2011-11-30
CO6361902A2 (es) 2012-01-20
EP2355803A4 (en) 2012-04-25
AU2009313928B2 (en) 2015-07-09
MX2011005076A (es) 2011-08-04
JP2012508769A (ja) 2012-04-12
IL212839A0 (en) 2011-07-31
CA2743675A1 (en) 2010-05-20
KR101685218B1 (ko) 2016-12-09
WO2010057007A1 (en) 2010-05-20
ZA201104382B (en) 2012-03-28
CN105532922A (zh) 2016-05-04
JP2014129371A (ja) 2014-07-10
JP5827709B2 (ja) 2015-12-02
US20110250299A1 (en) 2011-10-13
AU2015227472A1 (en) 2015-10-29
CN103349285A (zh) 2013-10-16
EP2711001A2 (en) 2014-03-26
IL212839A (en) 2016-09-29
EP2355803A1 (en) 2011-08-17

Similar Documents

Publication Publication Date Title
BRPI0916820A2 (pt) processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição de superfície em um paciente, e, uso de microcápsulas
BRPI0914527A2 (pt) método implementado por computador para identificar uma formulação de repintura e método implementado por computador para preparar um veículo
BR112012004424A2 (pt) aparelho e processo para embalar recipientes de produtos líquidos em feixes
BRPI0919192A2 (pt) Uso de lipídio, composição nutricional, e, processo para a produção de uma composição nutricional
BRPI0908221A2 (pt) processo para preparar uma formulação farmacêutica de agentes de contraste
BR112012029929A2 (pt) processo para preparar um produto de carga mineral tratada, produto de carga mineral tratada, uso de um produto de carga mineral tratada, e, material de película
BRPI0917617A2 (pt) Método para produzir açúcar líquido e método para produzir um produto químico
BRPI0916782A2 (pt) aparelho e processo para cortar rótulos adesivos
BRPI0910449A2 (pt) Processo para purificação de álcool de fermentação
BR112012029906A2 (pt) produto de carga mineral tratada, processo para preparar um produto de carga mineral tratada, uso de um produto de carga mineral tratada, e, material de película
BRPI0812427A2 (pt) Método para paroduzir um produto de fermentação de material contendo lignocelulose, e, processo para produzir um produto de fermentação de uma combinação de material contendo amido e material contendo lignocelulose.
BRPI0921399A2 (pt) composição de graxa lubrificante, processo para preparar composição lubrificante, e, uso de uma composição de graxa lubrificante
BRPI0920636A2 (pt) Biscoito, usos de um biscoito, e de goma guar, e, processo para fabricar um biscoito
BRPI0907820A2 (pt) Processo contínuo para preparação de amidas de ácidos graxos
BRPI0822946A2 (pt) Derivado de carboxiamida, processo para preparação de derivado de carboxiamida, composição farmacêutica e uso do derivado de carboxiamida
BRPI0820903A2 (pt) Processo para a preparação de uma composição de reticulação, composição de revestimento e método de uso da referida composição
BRPI1011562A2 (pt) método de uso de decoração temporária para customização em massa de recipientes de vidro reutilizáveis.
BRPI0912921A2 (pt) complexo metal-ligante, catalisador e processo para preparo de uma poliolefina
BRPI0909004A2 (pt) Processo para produção de biogás
BRPI0910545A2 (pt) processo contínuo para fazer composições farmacêuticas
BRPI0916632A2 (pt) método para composição de banner dinâmico
BRPI0910675A2 (pt) Processo para preparação de intermediários de naftalen-2-ilpirazol-3-ona úteis na síntese dos inibidores de receptores sigma
BRPI0912202A2 (pt) processo para a preparação de um painel
FI20085990L (fi) Modifioitu kuitutuote ja menetelmä sen valmistamiseksi
BRPI0920071A2 (pt) Processo para a preparacao de produtos de chocolate com recheio

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2493 DE 16-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.